FOUZEE SugarLin Herbal Formula Capsules Recalled for Undeclared Prescription Drugs
Shoppers-Plaza is recalling FOUZEE SugarLin Herbal Formula capsules because FDA testing found undeclared metformin and glyburide. The product was marketed without FDA approval.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall of an unapproved drug containing undeclared prescription medications (metformin and glyburide). Although no illnesses or injuries have been reported, undeclared prescription drugs pose a significant risk of harm.
Plain-English summary
Shoppers-Plaza is recalling FOUZEE SugarLin Herbal Formula capsules because FDA laboratory analysis confirmed the product contains undeclared metformin and glyburide, which are prescription medications used to treat diabetes. The product was marketed without an FDA-approved New Drug Application (NDA).
The affected product is FOUZEE SugarLin Herbal Formula, 180 capsules per bottle, UPC 8 26656 69047 7. Batch #001 with expiration date 09/10/2026 is recalled. Approximately 172 bottles were distributed nationwide via internet sales.
Consumers who purchased this product should stop using it immediately. If you have consumed this product and experience any health concerns, consult your healthcare provider. The product should be returned to the place of purchase for a refund or discarded.
The recalled product
- Product
- FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7
- Manufacturer
- SHOPPERS- PLAZA
- Category
- Drug
- Hazard
- undeclared-metformin
- undeclared-glyburide
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch # 001
- exp. date 09/10/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27